相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clear cell carcinoma of the ovary: a clinical and molecular perspective
Yasushi Iida et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2021)
The Frequency and Prognostic Significance of the Histologic Type in Early-stage Ovarian Carcinoma A Reclassification Study by the Spanish Group for Ovarian Cancer Research (GEICO)
Susanna Leskela et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
Mismatch Repair Deficiency in Ovarian Carcinoma Frequency, Causes, and Consequences
Susanna Leskela et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline
Panagiotis A. Konstantinopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study
U. A. Matulonis et al.
ANNALS OF ONCOLOGY (2019)
Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting
I. Ray-Coquard et al.
EJSO (2019)
Analysis of gene expression signatures identifies prognostic and functionally distinct ovarian clear cell carcinoma subtypes
Tuan Zea Tan et al.
EBIOMEDICINE (2019)
Exceptional Response to Pembrolizumab in a Metastatic, Chemotherapy/Radiation-Resistant Ovarian Cancer Patient Harboring a PD-L1-Genetic Rearrangement
Stefania Bellone et al.
CLINICAL CANCER RESEARCH (2018)
Histotype classification of ovarian carcinoma: A comparison of approaches
Lauren C. Peres et al.
GYNECOLOGIC ONCOLOGY (2018)
Mismatch repair status and PD-L1 expression in clear cell carcinomas of the ovary and endometrium
Brian C. Willis et al.
MODERN PATHOLOGY (2017)
The frequency of neoantigens per somatic mutation rather than overall mutational load or number of predicted neoantigens per se is a prognostic factor in ovarian clear cell carcinoma
Hirokazu Matsushita et al.
ONCOIMMUNOLOGY (2017)
Clear cell ovarian cancers with microsatellite instability: A unique subset of ovarian cancers with increased tumor-infiltrating lymphocytes and PD-1/PD-L1 expression
Brooke E. Howitt et al.
ONCOIMMUNOLOGY (2017)
Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial
Toru Sugiyama et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers
Keisuke Kataoka et al.
NATURE (2016)
Ovarian clear cell carcinoma, outcomes by stage: The MSK experience
Catherine A. Shu et al.
GYNECOLOGIC ONCOLOGY (2015)
Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology
Wataru Yamagami et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2015)
Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients
Tuan Zea Tan et al.
EMBO MOLECULAR MEDICINE (2014)
Gynecologic Cancer InterGroup (GCIG) Consensus Review for Clear Cell Carcinoma of the Ovary
Aikou Okamoto et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2014)
Prognostic Impact of Human Leukocyte Antigen Class I Expression and Association of Platinum Resistance with Immunologic Profiles in Epithelial Ovarian Cancer
Tasuku Mariya et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Analysis of outcomes in patients (pts) with recurrent ovarian clear cell carcinoma (ROCCC): Time to rethink our approach to treatment.
David Shao Peng Tan et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Clear cell carcinoma of the ovary: A report from the first Ovarian Clear Cell Symposium, June 24th, 2010
Michael S. Anglesio et al.
GYNECOLOGIC ONCOLOGY (2011)
ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
Matthew D. Wilkerson et al.
BIOINFORMATICS (2010)
Prognostic Relevance of Uncommon Ovarian Histology in Women With Stage III/IV Epithelial Ovarian Cancer
Helen J. Mackay et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2010)
Differences in Tumor Type in Low-stage Versus High-stage Ovarian Carcinomas
Martin Koebel et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2010)
Limited utility of conventional criteria for predicting unresectable disease in patients with advanced stage epithelial ovarian cancer
Ritu Salani et al.
GYNECOLOGIC ONCOLOGY (2008)
Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers
John K. Chan et al.
GYNECOLOGIC ONCOLOGY (2008)
Low response rate of second-line chemotherapy for recurrent or refractory clear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study
M. Takano et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
Clear-cell cancer of the ovary - is it chemosensitive?
S Pather et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2005)
Long-term prognosis of stage I ovarian carcinoma - Prognostic importance of intraoperative rupture
M Mizuno et al.
ONCOLOGY (2003)
分享论文
